Zydus Marks Biosimilar Entry Into Mexico With Bevacizumab Approval

The Firm Showed Initial Interest In The Region Back In 2012, Calling It A Future Home Market

 
• By Urtė Fultinavičiūtė
  
Mexico flag
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products